EventItemPast
 
 
 
     
    Fostering Competition in the Pharmaceutical Distribution Chain

    6/14/2017

    A USC-Brookings Schaeffer Initiative for Innovation in Health Policy Event

    Wednesday | June 14, 2017
    9:00 AM- 11:15 AM ET
    The Brookings Institution, Faulk Auditorium, 1775 Massachusetts Avenue NW, Washington, DC

    Although a great deal of attention concerning prescription drug prices centers on the prices charged by pharmaceutical manufacturers themselves, markups in the distribution chain—pharmacy benefit managers, wholesalers, and pharmacies—are often substantial. Despite the large role that these actors play, little is known about the discounts they negotiate or markups they charge and how those relate to what patients ultimately pay.

    On Wednesday, June 14, the USC-Brookings Schaeffer Initiative for Innovation in Health Policy will host a forum to explore the many segments of the drug distribution chain and examine proposals to reduce price markups through increased competition.

    The event will feature a presentation of two new papers: one estimating profitability in the distribution chains of both branded and generic drugs and another proposing a transparency scheme to foster competition in the distribution of generic pharmaceuticals. Stakeholder panels will follow the presentations of these two papers, to discuss approaches to increase competition in brand and generic drug distribution.

    Join the conversation on Twitter using #DistributionChain

    RSVP here to Attend the Event in Person
    Register to Watch the Live Webcast


    Agenda



    9:00 AM
    Opening Remarks | Dana Goldman,
    Leonard D. Schaeffer Director's Chair, USC Schaeffer Center for Health Policy & Economics; Distinguished Professor of Public Policy, Pharmacy & Economics

    9:05 AM
    Presentation of "The Flow of Funds in the Pharmaceutical Supply Chain"
    | Neeraj Sood, Professor of Public Policy and Director of Research, Schaeffer Center for Health Policy & Economics, University of Southern California

    9:20 AM
    Panel | Fostering Competition in the Brand Drug Distribution Chain

    Moderator: Paul Ginsburg, Director, Schaeffer Initiative for Innovation in Health Policy, Senior Fellow and Director, Center for Health Policy at Brookings
    Joshua Ofman, Senior Vice President, Global Value & Access, Amgen
    Matt Eyles, Executive Vice President, Policy and Regulatory Affairs, AHIP
    Lynn Quincy, Director, Healthcare Value Hub, Consumers Union
    Ed Adamcik, Chief Pharma Trade Relations Officer, Express Scripts


    10:00 AM Break


    10:15 AM | Presentation of "Would Price Transparency for Generic Drugs Lower Costs for Payers and Patients?" | Steve Lieberman, Nonresident Fellow, Center for Health Policy at Brookings

    10:30 AM 
    Panel | Fostering Competition in the Generic Drug Distribution Chain

    Moderator: Darius Lakdawalla, Professor and Quintiles Chair in Pharmaceutical Development and Regulatory Innovation, USC Schaeffer Center for Health Policy & Economics
    B. Douglas Hoey, CEO, National Community Pharmacists Association
    Tom Moriarty, Executive VP, Chief Policy & External Affairs Officer and General Counsel, CVS Health
    B. Douglas Hoey, CEO, National Pharmacists Association
    Christine Simmon, Senior Vice President, Policy & Strategic Alliances and Executive Director, Biosimilars Council, Assocation for Accessible Medicines
    Matt Eyles, Executive Vice President, Policy and Regulatory Affairs, AHIP


    RSVP here to Attend the Event in Person
    Register to Watch the Live Webcast


    The event will be live webcast. Follow us on Twitter @SchaefferCenter and @BrookingsEcon and use #DistributionChain


    This conference is a product of the Schaeffer Initiative for Innovation in Health Policy, a partnership between the Schaeffer Center for Health Policy & Economics at the University of Southern California and the Center for Health Policy at Brookings.